PNC Financial Services Group
FOLD

PNC Financial Services Group’s Amicus Therapeutics FOLD Stock Holding History

PNC Financial Services Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-625
Closed -$9.04K – 5265
2026
Q1 		$9.04K Buy
625
+82
+15% +$1.18K ﹤0.01% 4000
2025
Q4 		$7.73K Buy
543
+93
+21% +$914 ﹤0.01% 4056
2025
Q3 		$3.55K Buy
450
+218
+94% +$1.55K ﹤0.01% 4331
2025
Q2 		$1.33K Sell
232
-4,919
-95% -$31.7K ﹤0.01% 4515
2025
Q1 		$42K Buy
5,151
+3,497
+211% +$32.4K ﹤0.01% 3195
2024
Q4 		$15.6K Sell
1,654
-1,170
-41% -$12.2K ﹤0.01% 3635
2024
Q3 		$30.2K Buy
2,824
+371
+15% +$4.04K ﹤0.01% 3319
2024
Q2 		$24.3K Sell
2,453
-494
-17% -$5.07K ﹤0.01% 3380
2024
Q1 		$34.7K Buy
2,947
+1,472
+100% +$18.8K ﹤0.01% 3162
2023
Q4 		$20.9K Buy
1,475
+195
+15% +$2.21K ﹤0.01% 3405
2023
Q3 		$15.6K Hold
1,280
– – ﹤0.01% 3559
2023
Q2 		$16.1K Hold
1,280
– – ﹤0.01% 3647
2023
Q1 		$14.2K Hold
1,280
– – ﹤0.01% 3644
2022
Q4 		$15.6K Buy
+1,280
New +$14.4K ﹤0.01% 3592
2022
Q2 		– Sell
-94
Closed -$1K – 4570
2022
Q1 		$1K Hold
94
– – ﹤0.01% 4343
2021
Q4 		$1K Hold
94
– – ﹤0.01% 4283
2021
Q3 		$1K Hold
94
– – ﹤0.01% 4185
2021
Q2 		$1K Sell
94
-1,579
-94% -$15.4K ﹤0.01% 4108
2021
Q1 		$17K Buy
1,673
+160
+11% +$2.48K ﹤0.01% 3467
2020
Q4 		$36K Sell
1,513
-759
-33% -$15.5K ﹤0.01% 3086
2020
Q3 		$32K Buy
2,272
+1,326
+140% +$19.3K ﹤0.01% 2984
2020
Q2 		$14K Sell
946
-61
-6% -$743 ﹤0.01% 3350
2020
Q1 		$9K Buy
1,007
+935
+1,299% +$8.89K ﹤0.01% 3439
2019
Q4 		$1K Sell
72
-121,553
-100% -$1.11M ﹤0.01% 3878
2019
Q3 		$975K Sell
121,625
-49,947
-29% -$542K ﹤0.01% 1270
2019
Q2 		$2.14M Sell
171,572
-86,499
-34% -$1.1M ﹤0.01% 987
2019
Q1 		$3.51M Buy
+258,071
New +$3.15M ﹤0.01% 837
2018
Q4 		– Sell
-5,871
Closed -$71K – 4083
2018
Q3 		$71K Sell
5,871
-88,222
-94% -$1.23M ﹤0.01% 2795
2018
Q2 		$1.47M Sell
94,093
-28,329
-23% -$428K ﹤0.01% 1166
2018
Q1 		$1.84M Sell
122,422
-6,076
-5% -$92.5K ﹤0.01% 1063
2017
Q4 		$1.85M Sell
128,498
-64,023
-33% -$880K ﹤0.01% 1070
2017
Q3 		$2.9M Buy
192,521
+177,614
+1,191% +$2.35M ﹤0.01% 897
2017
Q2 		$150K Sell
14,907
-2,000
-12% -$16.1K ﹤0.01% 2300
2017
Q1 		$121K Hold
16,907
– – ﹤0.01% 2383
2016
Q4 		$84K Buy
16,907
+5,000
+42% +$34.6K ﹤0.01% 2556
2016
Q3 		$88K Buy
11,907
+2,000
+20% +$13.5K ﹤0.01% 2522
2016
Q2 		$54K Buy
9,907
+3,907
+65% +$27.3K ﹤0.01% 2798
2016
Q1 		$51K Buy
6,000
+2,500
+71% +$17.7K ﹤0.01% 2819
2015
Q4 		$34K Sell
3,500
-1,500
-30% -$13.5K ﹤0.01% 3020
2015
Q3 		$70K Buy
5,000
+2,000
+67% +$31.4K ﹤0.01% 2719
2015
Q2 		$42K Buy
+3,000
New +$36.1K ﹤0.01% 3122
2014
Q4 		– Sell
-2,000
Closed -$12K – 4183
2014
Q3 		$12K Sell
2,000
-6,000
-75% -$31.4K ﹤0.01% 3221
2014
Q2 		$27K Buy
+8,000
New +$18.8K ﹤0.01% 2816
2013
Q4 		– Sell
-8,000
Closed -$19K – 3436
2013
Q3 		$19K Buy
8,000
+5,000
+167% +$12.5K ﹤0.01% 2867
2013
Q2 		$7K Buy
+3,000
New +$9.22K ﹤0.01% 3234

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PNC Financial Services Group's FOLD Position: Q2 2026 in Review

PNC Financial Services Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 625 shares — an estimated $9.04K sold.

PNC Financial Services Group first reported a position in FOLD in Q2 2013 and held it in 45 quarters. The position peaked at $3.51M in Q1 2019. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • PNC Financial Services Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 625 Amicus Therapeutics shares in Q2 2026, an estimated $9.04K.
  • PNC Financial Services Group first reported a position in Amicus Therapeutics in Q2 2013 and held it in 45 quarters.
  • PNC Financial Services Group's Amicus Therapeutics position peaked at $3.51M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.